GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hero Technologies Inc (OTCPK:HENC) » Definitions » Valuation Rank

Hero Technologies (Hero Technologies) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Hero Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Hero Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hero Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Hero Technologies (Hero Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hero Technologies Inc (OTCPK:HENC) » Definitions » Valuation Rank
Comparable Companies
ECGS CPHI CLVR CNNC EVOK JUVAF BFRI STEK PRFX LSDI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
N/A
Address
8 The Green, Suite 4000, Dover, DE, USA, 19901
Website
https://www.herotechnologiesinc.com
Hero Technologies Inc is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations, and dispensaries. It focuses on two principal segments of the cannabis industry, cultivation, and the dispensary business model, including combinations.
Executives
Gina L. Serkasevich officer: CFO and Treasurer 310 COMMONS TRAIL LANE, HUFFMAN TX 77336
Keith Elliott Macdonald director 203 HERITAGE PLAVE, CALGARY A0 T3Z 3P3
K James Ebeling director 3726 WICKERSHAM LANE, HOUSTON TX 77027
James Douglas Brown director, 10 percent owner, officer: Secretary 11200 WESTHEIMER, SUITE 200, HOUSTON TX 77042
Holloman Value Holdings, Llc 10 percent owner 333 NORTH SAM HOUSTON PARKWAY EAST, SUITE 600, HOUSTON TX 77060
Robert Wesolek officer: Chief Financial Officer
Mark E. Stevenson director, officer: Secretary 8225 SAN DIEGO ST., ODESSA TX 79765
Eric C Prim director 4901 POLO PARKWAY, MIDLAND TX 79705
Grant M Petersen officer: Chief Executive Officer 1027 DAVIE ST., SUITE 482, VANCOUVER A1 V4E 1N9
Holloman Corp other: Affiliate 5257 WEST INTERSTATE 20, PO BOX 69410, ODESSA TX 79769
Holloman Oil & Gas Ltd. 10 percent owner 88 FORREST STREET, UNITS 8-9, COTTESLOE C3 6011
David R Lewis director 11115 EAST MONTGOMERY DRIVE, SUITE G, SPOKANE VALLEY WA 99206